Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 1
2001 3
2002 2
2003 6
2004 4
2005 8
2006 7
2007 6
2008 10
2009 7
2010 8
2011 15
2012 11
2013 14
2014 11
2015 12
2016 18
2017 22
2018 13
2019 14
2020 5
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

165 results
Results by year
Filters applied: . Clear all
Page 1
The Biomarkers for Acute Myocardial Infarction and Heart Failure.
Wang XY, Zhang F, Zhang C, Zheng LR, Yang J. Wang XY, et al. Biomed Res Int. 2020 Jan 17;2020:2018035. doi: 10.1155/2020/2018035. eCollection 2020. Biomed Res Int. 2020. PMID: 32016113 Free PMC article. Review.
The use of a large number of cardiovascular biomarkers, meant to complement the use of the electrocardiogram, echocardiography cardiac imaging, and clinical symptom assessment, has become a routine in clinical diagnosis, differential diagnosis, risk st …
The use of a large number of cardiovascular biomarkers, meant to complement the use of the electrocardiogram, echocardiography car
Contemporary NSTEMI management: the role of the hospitalist.
Pollack CV, Amin A, Wang T, Deitelzweig S, Cohen M, Slattery D, Fanikos J, DiLascia C, Tuder R, Kaatz S. Pollack CV, et al. Hosp Pract (1995). 2020 Feb;48(1):1-11. doi: 10.1080/21548331.2020.1701329. Epub 2020 Feb 20. Hosp Pract (1995). 2020. PMID: 31815570 Review.
Non-ST-segment elevation myocardial infarction (NSTEMI) is defined as elevated cardiac biomarkers of necrosis in the absence of persistent ST-segment elevation in the setting of anginal symptoms or other acute event. ...Given that the Society fo …
Non-ST-segment elevation myocardial infarction (NSTEMI) is defined as elevated cardiac biomarkers of necrosis in …
High-Sensitivity Cardiac Troponin I and Clinical Risk Scores in Patients With Suspected Acute Coronary Syndrome.
Chapman AR, Hesse K, Andrews J, Lee KK, Anand A, Shah ASV, Sandeman D, Ferry AV, Jameson J, Piya S, Stewart S, Marshall L, Strachan FE, Gray A, Newby DE, Mills NL. Chapman AR, et al. Circulation. 2018 Oct 16;138(16):1654-1665. doi: 10.1161/CIRCULATIONAHA.118.036426. Circulation. 2018. PMID: 30354460 Free PMC article.
BACKGROUND: High-sensitivity cardiac troponin assays can help to identify patients who are at low risk of myocardial infarction in the emergency department. We aimed to determine whether the addition of clinical risk scores would improve the saf …
BACKGROUND: High-sensitivity cardiac troponin assays can help to identify patients who are at low risk of myocardial
Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome.
Chapman AR, Lee KK, McAllister DA, Cullen L, Greenslade JH, Parsonage W, Worster A, Kavsak PA, Blankenberg S, Neumann J, Sörensen NA, Westermann D, Buijs MM, Verdel GJE, Pickering JW, Than MP, Twerenbold R, Badertscher P, Sabti Z, Mueller C, Anand A, Adamson P, Strachan FE, Ferry A, Sandeman D, Gray A, Body R, Keevil B, Carlton E, Greaves K, Korley FK, Metkus TS, Sandoval Y, Apple FS, Newby DE, Shah ASV, Mills NL. Chapman AR, et al. JAMA. 2017 Nov 21;318(19):1913-1924. doi: 10.1001/jama.2017.17488. JAMA. 2017. PMID: 29127948 Free PMC article. Review.
IMPORTANCE: High-sensitivity cardiac troponin I testing is widely used to evaluate patients with suspected acute coronary syndrome. ...STUDY SELECTION: Prospective studies measuring high-sensitivity cardiac troponin I concen …
IMPORTANCE: High-sensitivity cardiac troponin I testing is widely used to evaluate patients with suspected acute
A Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT).
Chew DP, Lambrakis K, Blyth A, Seshadri A, Edmonds MJR, Briffa T, Cullen LA, Quinn S, Karnon J, Chuang A, Nelson AJ, Wright D, Horsfall M, Morton E, French JK, Papendick C. Chew DP, et al. Circulation. 2019 Nov 5;140(19):1543-1556. doi: 10.1161/CIRCULATIONAHA.119.042891. Epub 2019 Sep 3. Circulation. 2019. PMID: 31478763 Clinical Trial.
BACKGROUND: High-sensitivity troponin assays promise earlier discrimination of myocardial infarction. ...CONCLUSIONS: This in-practice evaluation of a 0/1-hour hs-cTnT protocol embedded in ED care enabled more rapid discharge of patients with suspected …
BACKGROUND: High-sensitivity troponin assays promise earlier discrimination of myocardial infarction. ...CONCLUSIONS: T …
The HEART Pathway randomized trial: identifying emergency department patients with acute chest pain for early discharge.
Mahler SA, Riley RF, Hiestand BC, Russell GB, Hoekstra JW, Lefebvre CW, Nicks BA, Cline DM, Askew KL, Elliott SB, Herrington DM, Burke GL, Miller CD. Mahler SA, et al. Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2):195-203. doi: 10.1161/CIRCOUTCOMES.114.001384. Epub 2015 Mar 3. Circ Cardiovasc Qual Outcomes. 2015. PMID: 25737484 Free PMC article. Clinical Trial.
BACKGROUND: The HEART Pathway is a decision aid designed to identify emergency department patients with acute chest pain for early discharge. No randomized trials have compared the HEART Pathway with usual care. METHODS AND RESULTS: Adult emergency dep …
BACKGROUND: The HEART Pathway is a decision aid designed to identify emergency department patients with acute chest pai …
Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
Lindholm D, James SK, Gabrysch K, Storey RF, Himmelmann A, Cannon CP, Mahaffey KW, Steg PG, Held C, Siegbahn A, Wallentin L. Lindholm D, et al. JAMA Cardiol. 2018 Dec 1;3(12):1160-1166. doi: 10.1001/jamacardio.2018.3811. JAMA Cardiol. 2018. PMID: 30427997 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: The Platelet Inhibition and Patient Outcomes (PLATO) trial randomized 18 624 patients with acute coronary syndrome to ticagrelor or clopidogrel from October 2006 through July 2008. In this secondary analysis …
DESIGN, SETTING, AND PARTICIPANTS: The Platelet Inhibition and Patient Outcomes (PLATO) trial randomized 18 624 patients with …
Incidence and outcomes of unstable angina compared with non-ST-elevation myocardial infarction.
Puelacher C, Gugala M, Adamson PD, Shah A, Chapman AR, Anand A, Sabti Z, Boeddinghaus J, Nestelberger T, Twerenbold R, Wildi K, Badertscher P, Rubini Gimenez M, Shrestha S, Sazgary L, Mueller D, Schumacher L, Kozhuharov N, Flores D, du Fay de Lavallaz J, Miro O, Martín-Sánchez FJ, Morawiec B, Fahrni G, Osswald S, Reichlin T, Mills NL, Mueller C. Puelacher C, et al. Heart. 2019 Sep;105(18):1423-1431. doi: 10.1136/heartjnl-2018-314305. Epub 2019 Apr 24. Heart. 2019. PMID: 31018955
OBJECTIVE: Assess the relative incidence and compare characteristics and outcome of unstable angina (UA) and non-ST-elevation myocardial infarction (NSTEMI). DESIGN: Two independent prospective multicentre diagnostic studies (Advantageous Predictors of Acute
OBJECTIVE: Assess the relative incidence and compare characteristics and outcome of unstable angina (UA) and non-ST-elevation myocardial
COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.
Tajbakhsh A, Gheibi Hayat SM, Taghizadeh H, Akbari A, Inabadi M, Savardashtaki A, Johnston TP, Sahebkar A. Tajbakhsh A, et al. Expert Rev Anti Infect Ther. 2020 Sep 28:1-13. doi: 10.1080/14787210.2020.1822737. Online ahead of print. Expert Rev Anti Infect Ther. 2020. PMID: 32921216
Myocardial damage is closely related to the severity of the disease and even the prognosis in patients with COVID-19. ...Abbreviations: ICU: An intensive care unit; 2019-nCoV: 2019 novel coronavirus; ACEI: ACE inhibitor; ACS: Acute coronary
Myocardial damage is closely related to the severity of the disease and even the prognosis in patients with COVI
High-Sensitivity Troponin and the Application of Risk Stratification Thresholds in Patients With Suspected Acute Coronary Syndrome.
Bularga A, Lee KK, Stewart S, Ferry AV, Chapman AR, Marshall L, Strachan FE, Cruickshank A, Maguire D, Berry C, Findlay I, Shah ASV, Newby DE, Mills NL, Anand A. Bularga A, et al. Circulation. 2019 Nov 5;140(19):1557-1568. doi: 10.1161/CIRCULATIONAHA.119.042866. Epub 2019 Sep 1. Circulation. 2019. PMID: 31475856 Free PMC article.
We evaluate the safety and effectiveness of risk stratification thresholds in patients with suspected acute coronary syndrome. METHODS: Consecutive patients with suspected acute coronary syndrome (n=48 282) were enrolled in …
We evaluate the safety and effectiveness of risk stratification thresholds in patients with suspected acute coronary
165 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page